Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
letter
. 2004 Jun;63(6):747–748. doi: 10.1136/ard.2003.007138

Polyclonal immunoglobulins for intravenous use induce interleukin 10 release in vivo and in vitro

R Lories, D Casteels-Van, J Ceuppens, S W Van Gool
PMCID: PMC1755027  PMID: 15140788

Full Text

The Full Text of this article is available as a PDF (70.6 KB).

Figure 1 .

Figure 1

(A) Serum concentrations of interleukin10 (IL10) are increased immediately after infusion of polyclonal immunoglobulins for intravenous use (IVIg) in immunodeficient patients; (B) IVIg rapidly and strongly increase IL10 production in whole blood in vitro (one of seven experiments shown); (C) anti-FcR antibodies can inhibit IVIg induced IL10 production (one of three experiments shown).


Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES